ALEC alector.com Expected Profit
Alector, Inc. (ALEC) is creating a biopharmaceutical environment to combat Alzheimer's disease through partnerships with industry behemoths. The company's innovations are based on activating brain immunity to eliminate the causes of neurodegeneration. The company's cash return forecast on the GURU.Markets platform contains up-to-date data, where the latest value is recorded as . The stability of clinical trials is ensured by strictly regulated logistics for specialized reagents.
Financial and market metric breakdowns for Alector Therapeutics (ALEC)
- share price and consensus valuation forecast:
- market capitalization data:
- company book value details:
- debt and solvency information:
Total Debt to Equity Ratio Alector, Inc.|ALEC - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity Alector Inc.|ALEC - Company Cumulative Debt|Debt to Book Capitalization Ratio Alector Therapeutics|ALEC - Company Long-Term Loans and Borrowings|Company Current Liabilities Alector|Quick Ratio alector.com
- earnings and valuation multiples information:
ALEC - Net Financial Result|Expected Profit Alector, Inc.|ALEC - Price to Earnings Multiple|Forward P/E Multiple alector.com|ALEC - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio Alector, Inc.|ALEC - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Alector|ALEC - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months alector.com|ALEC - Earnings per share growth in current year|Earnings growth forecast for next year Alector, Inc.
- total revenue and sales volume data:
Fundamental company analysis:ALEC, Alector Inc.
This indicator calculates expected net profit adjusted for currency volatility, serving as an objective benchmark for the asset's fundamental value. By analyzing the business's projected earnings, investors assess the monetization potential of Alector, Inc. (ALEC) immuno-neurological developments in dementia therapy through strategic alliances with pharma behemoths, which determines the long-term consensus on the company's capitalization.
Competitor analysis for Alector, Inc.
BIIB (Biogen) - Projected Future Earnings|Net Profit Forecast NBIX (Neurocrine Biosciences, Inc.)|Projected Future Earnings RGC|Axsome Corp - Net Profit Forecast|Projected Future Earnings ACAD (ACADIA Corp)|XENE: Net Profit Forecast|Viking Therapeutics Inc - Projected Future Earnings|Expected Net Profit Supernus Pharmaceuticals, Inc.|Catalyst Pharmaceuticals Inc (CPRX) - Expected Profit|DNLI (Denali Therapeutics Inc) - Expected Profit|Expected Profit Harmony Biosciences Holdings, Inc.|Expected Profit BHVN|Future Profit AMLX (Amylyx Pharmaceuticals, Inc.)|Future Net Profit TRVI|Expected Profit Praxis Precision Medicines, Inc. PRAX|Anavex Corp - Expected Profit|CBLL: Future Profit|Expected Net Income PRTA (prothena.com)|Annexon Inc. (ANNX) - Expected Profit|Omeros Corp. - Expected Net Income|NGNE (Neurogene Therapeutics) - Projected Future Earnings|Future Profit AC Immune Corp (ACIU)|Expected Profit Voyager Therapeutics (VYGR)|NMRA (Neumora Therapeutics) - Expected Net Income|Expected Profit Scilex Holding Co. SCLX|Expected Net Income TVGN|ACOG - Expected Profit|Expected Net Income CGTX (Cognition Therapeutics, Inc.)|IKT: Projected Future Earnings|Expected Net Profit cassavasciences.com (SAVA)|ASRT (Assertio Holdings, Inc.) - Projected Future Earnings|Future Profit coyatherapeutics.com (COYA)|Future Profit VTGN (vistagen.com)|Company Profit Forecast Ovid Rx|Projected Future Earnings ABOS (acumenpharm.com)|CRVO: Net Profit Forecast|Alterity Therapeutics Ltd. - Projected Future Earnings|Expected Net Profit clene.com|pepgen.com (PEPG) - Expected Profit|Expected Net Profit Jupiter Neurosciences, Inc. (JUNS)|Expected Profit Relmada Therapeutics|Net Profit Forecast ANVS (Annovis Bio, Inc.)|Projected Future Earnings GRCE|Company Profit Forecast Firefly Neuroscience, Inc.|Expected Profit anewmeds.com KLTO|Company Profit Forecast NeuroSense Therapeutics (NRSN)|RVPH: Future Profit|MTVA - Projected Future Earnings|NRXS (neuraxis.com) - Future Profit|Expected Net Profit Helius Medical Technologies Inc. (HSDT)|Expected Profit Passage Bio Corp|Future Profit Neuphoria Therapeutics (NEUP)|Projected Future Earnings NERV|ATHA - Expected Net Profit|Projected Future Earnings ADXN (addextherapeutics.com)|Alzamend (ALZN) - Expected Net Profit|CYCN: Future Profit|Expected Net Profit Protagenic Therapeutics Inc.|pasitheaclinics.com (KTTA) - Expected Profit|Expected Net Profit Cortigent Medical (CRGT)|ATXI (Avenue Therapeutics Inc) - Projected Future Earnings|BCLI (Brainstorm Cell Therapeutics Inc.) - Future Net Profit|Projected Future Earnings CARA|CHRO - Expected Net Profit|Eliem Therapeutics - Future Profit|Intra-Cellular (ITCI) - Expected Net Profit|LBPH - Expected Profit|MRNS - Projected Future Earnings|NKGN: Projected Future Earnings|NeuroBo Pharma (NRBO) - Projected Future Earnings|Future Profit SAGE|Net Profit Forecast SNPX (Synaptogenix, Inc.)|Expected Profit Trevena, Inc (TRVN)|VIGL (Vigil Neuroscience Inc.) - Expected Net Income|Expected Profit Anew Medical WENA|Future Net Profit CERE (Cerevel)
